Axsome Therapeutics Income from Continuous Operations 2014-2025 | AXSM
Axsome Therapeutics income from continuous operations for the twelve months ending June 30, 2025 was $-0.247B, a 19.98% decline year-over-year.
- Axsome Therapeutics annual income from continuous operations for 2024 was $-0.287B, a 20.05% increase from 2023.
- Axsome Therapeutics annual income from continuous operations for 2023 was $-0.239B, a 27.84% increase from 2022.
- Axsome Therapeutics annual income from continuous operations for 2022 was $-0.187B, a 43.5% increase from 2021.